Number of Current Board & Advisor Roles 17
Number of Founded Organizations 1
  • Investor Type  Investment Partner

Beth Seidenberg is a partner at Kleiner Perkins Caufield & Byers focused on life science investing. She works with entrepreneurs to develop companies with breakthrough technology for treating patients and improving health.

Since joining KPCB in 2005, Beth has incubated five companies and serves on the board of directors of 3-V Biosciences,

Armo Biosciences, Atara, Auxogyn, Breathe Technologies, Epizyme, iPierian, Redbrick Health and TESARO.

Before joining KPCB, Beth was senior vice president of development and chief medical officer of Amgen, Inc.

Earlier in her career, she was a senior executive in research and development at Bristol-Myers Squibb Co. and Merck & Co., Inc. Under her leadership, 10 innovative products were developed and marketed globally and achieved more than 40 regulatory approvals.

Beth received her B.S. degree from Barnard College and her M.D. from the University of Miami. She completed her post-graduate training at Johns Hopkins University, George Washington University and the National Institutes of Health.

Partner Investments


Number of Current Jobs 2
Number of Past Jobs 3
Beth Seidenberg has 2 current jobs as Managing Director at Westlake Village BioPartners and General Partner at Kleiner Perkins. Additionally, Beth Seidenberg has had 3 past jobs including Senior Executive, Research and Development at Bristol Myers Squibb.
Organization Name  
Title At Company  
Start Date  
End Date  
Bristol Myers Squibb
Senior Executive, Research and Development
Amgen Ventures
Vice President, Global Development, and Chief Medical Officer
Senior Executive - R&D

Board and Advisor Roles

Number of Current Board & Advisor Roles 17
Beth Seidenberg holds 17 board and advisor roles including Board Member at Vera Therapeutics, Board Member at Neuron23, and Member of the Board of Directors at Rapt Therapeutics.

Related Hubs



Number of Events 2
Beth Seidenberg has participated in 2 events. They most recently attended, or will attend, Techcrunch Disrupt SF 2015 on Sep 19, 2015.

Recent News and Activity

Number of News Articles 112